Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 47335-724

4 FDA label images from Sun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 47335-724). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-fexofenadine-showbox (Spl Fexofenadine Showbox)

Spl-fexofenadine-showbox (Spl Fexofenadine Showbox)
Drug Facts panel for Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride extended-release tablets, 60 mg/120 mg. The text details active ingredients, uses, warnings, directions, and inactive ingredients. It includes advice for use, storage instructions, and contact information for questions. The label emphasizes non-drowsy allergy and congestion relief for nasal and sinus symptoms.*
FDA Label Image

Spl-fexofenadine-label1 (Spl Fexofenadine Label1)

Spl-fexofenadine-label1 (Spl Fexofenadine Label1)
Label for Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets, USP 60 mg/120 mg by Sun Pharmaceutical Industries, Inc. The label indicates it is an allergy and congestion treatment with 30 film-coated tablets providing 12-hour relief, used for nasal and sinus congestion, sneezing, runny nose, itchy watery eyes, and itchy nose or throat due to colds or allergies. The tablet is non-drowsy and contains antihistamine and nasal decongestant.*
FDA Label Image

Spl-fexofenadine-label2 (Spl Fexofenadine Label2)

Spl-fexofenadine-label2 (Spl Fexofenadine Label2)
Drug Facts panel continued for Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride extended-release tablets. The text includes detailed information on uses, warnings, precautions, and directions for use, addressing allergy symptom relief and advising consultation with a doctor for specific health conditions. It also includes instructions for when not to exceed the recommended dose and notes about antacids and juice interactions.*
FDA Label Image

Spl-fexofenadine-label3 (Spl Fexofenadine Label3)

Spl-fexofenadine-label3 (Spl Fexofenadine Label3)
Drug Facts panel continuing with warnings about allergic reactions and symptoms, instructions for pregnant or breastfeeding individuals, and keeping the drug out of children's reach. Directions advise adults and children over 12 to take one tablet every 12 hours, not exceeding two tablets in 24 hours, and not for use in children under 12. Additional information on storage and sealing, inactive ingredients list including various cellulose types and stearic acid, and a toll-free number for questions is provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.